Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by Redbaron2211on Dec 03, 2021 1:29am
171 Views
Post# 34193418

RE:RE:P.T. The bag will heal people

RE:RE:P.T. The bag will heal peopleIt is relevant that Frank has done very little for the company up until this point.  It shows something fundamental is changing within the company.  He co founded Angiotech, ID Biomedical, Xenon Pharma. He wouldn't be investing time here unless a licensing deal or some other catalyst was about to come to fruition adding another multi billion dollar company to his list.   The high you get from being involved with a company adding billions in valuation is likely addictive.   Money is motivation but I'm sure there would be plenty of motivation in the nostalgia and gratification of being involved in potentially curing T1D with an old friend. 

Markham I would expect the market cap to 3x with in 4 months of a licensing deal w/ big pharma and plently of runway after that.       
<< Previous
Bullboard Posts
Next >>